Clinical Trial Update: Phase 2 Study to Evaluation the Safety and Efficacy of Orally Administered KL7016 in Patients With Dry Eye Syndrome [Phase 2]

View source ↗

Summary

Phase 2 study evaluating safety and efficacy of KL7016 taken orally in patients with Dry Eye Syndrome has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Syndrome

Drugs mentioned

• KL7016

Snippet

Sponsor: Yungjin Pharm. Co., Ltd. | Conditions: Dry Eye Syndrome | Phase 2 | Status: COMPLETED